(0.29%) 5 106.25 points
(0.70%) 38 651 points
(0.58%) 17 753 points
(0.00%) $78.95
(-0.20%) $2.03
(0.07%) $2 311.30
(-0.09%) $26.81
(1.77%) $979.60
(-0.18%) $0.931
(-0.64%) $10.92
(-0.25%) $0.796
(0.49%) $91.57
0.46% ¥ 2 644.00
Live Chart Being Loaded With Signals
CMIC HOLDINGS Co., Ltd. provides various services for the pharmaceutical industry in Japan. The company operates in five segments: Contract Research Organization, Contract Development and Manufacturing Organization, Contract Sales Organization, Healthcare, and Innovative Pharma Model...
Stats | |
---|---|
Tagesvolumen | 283 600 |
Durchschnittsvolumen | 40 111.00 |
Marktkapitalisierung | 44.64B |
EPS | ¥0 ( 2024-04-26 ) |
Nächstes Ertragsdatum | ( ¥0 ) 2024-07-29 |
Last Dividend | ¥5.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 8.48 |
ATR14 | ¥3.11 (0.00%) |
Volumen Korrelation
CMIC HOLDINGS Co., Ltd. Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
CMIC HOLDINGS Co., Ltd. Korrelation - Währung/Rohstoff
CMIC HOLDINGS Co., Ltd. Finanzdaten
Annual | 2023 |
Umsatz: | ¥104.70B |
Bruttogewinn: | ¥24.70B (23.59 %) |
EPS: | ¥416.23 |
FY | 2023 |
Umsatz: | ¥104.70B |
Bruttogewinn: | ¥24.70B (23.59 %) |
EPS: | ¥416.23 |
FY | 2022 |
Umsatz: | ¥108.46B |
Bruttogewinn: | ¥26.26B (24.21 %) |
EPS: | ¥469.41 |
FY | 2021 |
Umsatz: | ¥85.79B |
Bruttogewinn: | ¥17.73B (20.66 %) |
EPS: | ¥111.87 |
Financial Reports:
No articles found.
CMIC HOLDINGS Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥10.00 (N/A) |
¥0 (N/A) |
¥5.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥2.50 | 2004-09-27 |
Last Dividend | ¥5.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 39 | -- |
Total Paid Out | ¥394.60 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.76 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.88 | |
Div. Directional Score | 7.89 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8068.T | Ex Dividend Knight | 2024-01-30 | Semi-Annually | 0 | 0.00% | |
7350.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6590.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
5936.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4617.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3852.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
3093.T | Ex Dividend Knight | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
1967.T | Ex Dividend Junior | 2024-03-18 | Annually | 0 | 0.00% | |
9531.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8424.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0572 | 1.500 | 8.86 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0785 | 1.200 | 7.38 | 8.86 | [0 - 0.3] |
returnOnEquityTTM | 0.147 | 1.500 | 9.48 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.01 | 0.800 | 4.97 | 3.97 | [1 - 3] |
quickRatioTTM | 1.503 | 0.800 | 5.87 | 4.69 | [0.8 - 2.5] |
cashRatioTTM | 0.617 | 1.500 | 7.69 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0385 | -1.500 | 9.36 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 57.84 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 453.56 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 453.56 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0737 | -1.500 | 9.71 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.223 | 1.000 | 9.61 | 9.61 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0745 | 1.000 | -0.509 | -0.509 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.93 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 1.372 | 0.800 | 4.19 | 3.35 | [0.5 - 2] |
Total Score | 11.90 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 8.38 | 1.000 | 9.25 | 0 | [1 - 100] |
returnOnEquityTTM | 0.147 | 2.50 | 9.67 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 453.56 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.702 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 453.56 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.740 | 1.500 | -8.27 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0823 | 1.000 | -0.443 | 0 | [0.1 - 0.5] |
Total Score | 3.88 |
CMIC HOLDINGS Co., Ltd.
CMIC HOLDINGS Co., Ltd. provides various services for the pharmaceutical industry in Japan. The company operates in five segments: Contract Research Organization, Contract Development and Manufacturing Organization, Contract Sales Organization, Healthcare, and Innovative Pharma Model. It offers clinical trial services, including clinical operations and trials, data management, clinical caretaker, medical writing, patient recruitment, pharmacovigilance, project management, audit and quality assurance, and statistical analysis; and clinical site network, CMC, drug development, health economics and outcome research, market entry/out-licensing, medical devices and in vitro diagnostic consulting, medical writing, national health insurance pricing, and product life cycle management consulting services. The company also provides development and manufacturing services, including commercial supply, contract development and manufacturing, investigational product manufacturing, packaging and labeling, release and stability tests, technology transfer, as well as formulation, process, and analytical development services; and laboratory services, such as bioanalysis and GLP analysis, biomarkers, CMC and GMP analysis, large molecule, oligonucleotides, small molecule, and toxicity, as well as safety pharmacology, in vitro and in vivo, and non-clinical studies. In addition, it offers patient and healthcare services, such as drug adherence support program, harmo, Helc+, prescription drug database, and selcheck services; and post-marketing surveillance, self-inspection, regulatory affairs consulting, regulatory submissions and correspondence, sales and marketing, clinical research coordinating, clinical site administration, and site management services. CMIC HOLDINGS Co., Ltd. has a partnership with Science 37, Inc. to decentralize clinical trials and enhance the development of treatments. The company was incorporated in 1985 and is headquartered in Tokyo, Japan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.